Keyphrases
Immunogenicity
100%
B Domain
100%
Phospholipid Vesicles
100%
Recombinant Factor VIII
100%
Vesicle Aggregation
100%
Human Factor VIII
80%
Hemophilia
60%
Membrane Binding
40%
Cryogenic Electron Microscopy
40%
Physiological Condition
40%
Negatively Charged Phospholipids
40%
Porcine Factor VIII
40%
Effective Therapy
20%
Biophysical Properties
20%
Serine Protease
20%
Blood Plasma
20%
Coagulation
20%
Secondary Structure
20%
Intravenous Administration
20%
Dynamic Light Scattering
20%
Factor IXa
20%
Phospholipid Membrane
20%
Direct Method
20%
Circular Dichroism
20%
Proposed Methodology
20%
Plasma Glycoproteins
20%
Bound States
20%
Factor VIII Concentrate
20%
Factor VIIIa
20%
Multi-domain
20%
Hereditary Bleeding Disorders
20%
Tenase Complex
20%
Activated Platelets
20%
Membrane-bound Form
20%
Functional Membrane
20%
Micro Organizations
20%
Plasma-derived Factor VIII
20%
Structure Distribution
20%
Protein Therapeutics
20%
Vesicle Suspensions
20%
B-domain Deleted Recombinant Factor VIII
20%
Therapeutic Properties
20%
Medicine and Dentistry
Immunogenicity
100%
Blood Clotting Factor 8
100%
Phospholipid Vesicle
100%
Haemophilia A
17%
Cryoelectron Microscopy
11%
Phospholipid Membrane
5%
Blood Proteins
5%
Thrombocyte Activation
5%
Bleeding Disorder
5%
Blood Plasma
5%
Serine Proteinase
5%
Blood Clotting Factor 8 Concentrate
5%
Protein Secondary Structure
5%
Tenase
5%
Thrombocyte Membrane
5%
Photon Correlation Spectroscopy
5%
Circular Dichroism
5%
Biochemistry, Genetics and Molecular Biology
Immunogenicity
100%
Factor VIII
100%
Phospholipid Vesicle
100%
Haemophilia A
16%
Blood Plasma
11%
Cryoelectron Microscopy
11%
Protein Secondary Structure
5%
Phospholipid Membrane
5%
Serine Protease
5%
Thrombocyte Activation
5%
Thrombocyte Membrane
5%
Tenase
5%
Dynamic Light Scattering
5%
Blood Proteins
5%
Deficiency
5%
Circular Dichroism
5%
Immunology and Microbiology
Immunogenicity
100%
Factor VIII
100%
Phospholipid Vesicle
100%
Blood Plasma
11%
Cryo-Electron Microscopy
11%
Glycoprotein
5%
Light Scattering
5%
Protein Secondary Structure
5%
Thrombocyte Activation
5%
Phospholipid Membrane
5%
Thrombocyte Membrane
5%
Serine
5%
Pharmacology, Toxicology and Pharmaceutical Science
Immunogenicity
100%
Phospholipid
100%
Blood Clotting Factor 8
100%
Haemophilia A
17%
Cryo-Electron Microscopy
11%
Serine Proteinase
5%
Plasma Protein
5%
Bleeding Disorder
5%
Blood Clotting Factor 8 Concentrate
5%
Light Scattering
5%